Aroa Biosurgery Statistics
Total Valuation
Aroa Biosurgery has a market cap or net worth of 86.04 million. The enterprise value is 77.23 million.
| Market Cap | 86.04M |
| Enterprise Value | 77.23M |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.35% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 259.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.77 |
| PB Ratio | 1.47 |
| P/TBV Ratio | 1.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -15.93 |
| EV / Sales | 1.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -15.32 |
Financial Position
The company has a current ratio of 8.53, with a Debt / Equity ratio of 0.07.
| Current Ratio | 8.53 |
| Quick Ratio | 6.80 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.87 |
| Interest Coverage | -19.49 |
Financial Efficiency
Return on equity (ROE) is -8.05% and return on invested capital (ROIC) is -6.10%.
| Return on Equity (ROE) | -8.05% |
| Return on Assets (ROA) | -5.67% |
| Return on Invested Capital (ROIC) | -6.10% |
| Return on Capital Employed (ROCE) | -10.08% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.70 |
| Inventory Turnover | 1.26 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 3,088 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Aroa Biosurgery had revenue of 48.59 million and -4.85 million in losses. Loss per share was -0.01.
| Revenue | 48.59M |
| Gross Profit | 42.10M |
| Operating Income | -6.30M |
| Pretax Income | -4.56M |
| Net Income | -4.85M |
| EBITDA | -4.14M |
| EBIT | -6.30M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 13.93 million in cash and 4.38 million in debt, giving a net cash position of 9.55 million.
| Cash & Cash Equivalents | 13.93M |
| Total Debt | 4.38M |
| Net Cash | 9.55M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 58.58M |
| Book Value Per Share | 0.17 |
| Working Capital | 35.94M |
Cash Flow
In the last 12 months, operating cash flow was -3.15 million and capital expenditures -1.89 million, giving a free cash flow of -5.04 million.
| Operating Cash Flow | -3.15M |
| Capital Expenditures | -1.89M |
| Free Cash Flow | -5.04M |
| FCF Per Share | n/a |
Margins
Gross margin is 86.63%, with operating and profit margins of -12.97% and -9.97%.
| Gross Margin | 86.63% |
| Operating Margin | -12.97% |
| Pretax Margin | -9.39% |
| Profit Margin | -9.97% |
| EBITDA Margin | -8.53% |
| EBIT Margin | -12.97% |
| FCF Margin | n/a |
Dividends & Yields
Aroa Biosurgery does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.35% |
| Shareholder Yield | -0.35% |
| Earnings Yield | -5.63% |
| FCF Yield | -5.86% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Aroa Biosurgery has an Altman Z-Score of 10.32.
| Altman Z-Score | 10.32 |
| Piotroski F-Score | n/a |